{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:47:36Z","timestamp":1780462056469,"version":"3.54.1"},"reference-count":66,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T00:00:00Z","timestamp":1250467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Proliferation"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives:\u2002<\/jats:bold>Recombinant human granulocyte colony\u2010stimulating factor (rhG\u2010CSF) is widely used as treatment for granulocytopaenia during cytotoxic chemotherapy; however, optimal scheduling of this pharmaceutical is unknown. Biomathematical models can help to pre\u2010select optimal application schedules but precise pharmacokinetic properties of the pharmaceuticals are required at first. In this study, we have aimed to construct a pharmacokinetic model of G\u2010CSF derivatives filgrastim and pegfilgrastim in mice.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Healthy CD\u20101 mice and those with cyclophosphamide\u2010induced granulocytopaenia were studied after administration of filgrastim and pegfilgrastim in different dosing and timing schedules. Close meshed time series of granulocytes and G\u2010CSF plasma concentrations were determined. An ordinary differential equations model of pharmacokinetics was constructed on the basis of known mechanisms of drug distribution and degradation.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Predictions of the model fit well with all experimental data for both filgrastim and pegfilgrastim. We obtained a unique parameter setting for all experimental scenarios. Differences in pharmacokinetics between filgrastim and pegfilgrastim can be explained by different estimates of model parameters rather than by different model mechanisms. Parameter estimates with respect to distribution and clearance of the drug derivatives are in agreement with qualitative experimental results.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>Dynamics of filgrastim and pegfilgrastim plasma levels can be explained by the same pharmacokinetic model but different model parameters. Beause of a strong clearance mechanism mediated by granulocytes, granulocytotic and granulocytopaenic conditions must be studied simultaneously to construct a reliable model. The pharmacokinetic model will be extended to a murine model of granulopoiesis under chemotherapy and G\u2010CSF application.<\/jats:p>","DOI":"10.1111\/j.1365-2184.2009.00638.x","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T01:31:00Z","timestamp":1250559060000},"page":"813-822","source":"Crossref","is-referenced-by-count":17,"title":["A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide\u2010induced granulocytopaenia"],"prefix":"10.1111","volume":"42","author":[{"given":"M.","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Emmrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kamprad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-2-138"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(03)00326-9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21847"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0034-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2003.05.002"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg249"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262001-00007"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.V71.3.640.640","article-title":"Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM\u2010CSF or G\u2010CSF","volume":"71","author":"Begley CG","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200701000-00003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.8.2012.2012"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4162"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.23.9499"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.2003.00251.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2420009"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80135-5"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.163"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1734"},{"key":"e_1_2_6_19_2","first-page":"1313","article-title":"The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony\u2010stimulating factor (G\u2010CSF) in\u2003vivo and in\u2003vitro","volume":"25","author":"Ericson SG","year":"1997","journal-title":"Exp. Hematol."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10434"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03164.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2003.12.011"},{"key":"e_1_2_6_23_2","first-page":"6615","article-title":"Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony\u2010stimulating factor (KRN8601) in the rat","volume":"50","author":"Tanaka H","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(02)80003-2"},{"key":"e_1_2_6_25_2","first-page":"3710","article-title":"Pharmacokinetics of recombinant human granulocyte colony\u2010stimulating factor conjugated to polyethylene glycol in rats","volume":"51","author":"Tanaka H","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20024"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000103953"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf130"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X219599"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000094890"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm541"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0306"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00285-004-0295-1"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05957.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01876146"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.8.2506"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1289"},{"key":"e_1_2_6_38_2","first-page":"1497","article-title":"Serum levels of endogenous and exogenous granulocyte colony\u2010stimulating factor after autologous blood stem cell transplantation","volume":"23","author":"Shimazaki C","year":"1995","journal-title":"Exp. Hematol."},{"key":"e_1_2_6_39_2","first-page":"27","article-title":"Effectiveness of cytopenia prophylaxis for different Filgrastim and Pegfilgrastim schedules in a chemotherapy mouse model","volume":"3","author":"Scholz M","year":"2009","journal-title":"Biologics"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0022-3565(25)09527-8","article-title":"Saturable uptake of a recombinant human granulocyte colony\u2010stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in\u2003vivo","volume":"273","author":"Kuwabara T","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn051"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.015669"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602539608994020"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.11.2849.2849"},{"key":"e_1_2_6_45_2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-3565(25)23988-X","article-title":"Nonlinear pharmacokinetics of a recombinant human granulocyte colony\u2010stimulating factor derivative (nartograstim): species differences among rats, monkeys and humans","volume":"271","author":"Kuwabara T","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_46_2","first-page":"E1","article-title":"Receptor\u2010mediated clearance of G\u2010CSF derivative nartograstim in bone marrow of rats","volume":"269","author":"Kuwabara T","year":"1995","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_47_2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood.V74.4.1303.1303","article-title":"Evidence for a novel in\u2003vivo control mechanism of granulopoiesis: mature cell\u2010related control of a regulatory growth factor","volume":"74","author":"Layton JE","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.1.147"},{"key":"e_1_2_6_49_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V83.1.119.bloodjournal831119","article-title":"Granulocyte colony\u2010stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells","volume":"83","author":"Steinman RA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.57.6.964"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791"},{"key":"e_1_2_6_52_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.32604\/biocell.2005.29.007","article-title":"Effects of filgrastim on granulopoietic cells of mice pretreated with methotrexate","volume":"29","author":"Barrios L","year":"2005","journal-title":"Biocell"},{"issue":"2","key":"e_1_2_6_53_2","first-page":"S126","article-title":"Effects of G\u2010CSF and antibiotic prophylaxis in a 2\u2003\u00d7\u20032 factorial design on outcome in septic rats","volume":"53","author":"Bauhofer A","year":"2004","journal-title":"Inflamm. Res."},{"key":"e_1_2_6_54_2","first-page":"2085","article-title":"Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r\u2010metHu G\u2010CSF) or filgrastim SD\/01 (PEG\u2010r\u2010metHu G\u2010CSF)","volume":"7","author":"Lord BI","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.146"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(99)00112-5"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.08.019"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200304000-00002"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2004.00503.x"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1033"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1021\/bp020017g"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200822050-00004"},{"key":"e_1_2_6_63_2","article-title":"Pharmacokinetic and Pharmacodynamic modelling of the novel human G\u2010CSF derivative Maxy\u2010G34 and Pegfilgrastim in the rat","author":"Scholz M","journal-title":"Cell Proliferation"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011534529622"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006288731"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2004.11.026"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2008.09.043"}],"container-title":["Cell Proliferation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2184.2009.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2184.2009.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:38:18Z","timestamp":1739302698000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2184.2009.00638.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,27]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1365-2184.2009.00638.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2184.2009.00638.x","archive":["Portico"],"relation":{},"ISSN":["0960-7722","1365-2184"],"issn-type":[{"value":"0960-7722","type":"print"},{"value":"1365-2184","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,27]]}}}